SEC Form 4 · accession 0001144204-15-002000
CHAMPIONS ONCOLOGY, INC. · CSBR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joel Ackerman
Officer — Chief Executive Officer · Director
Period of report
Dec 1, 2014
Accepted (ET)
Jan 13, 2015 · 3:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000771856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Promissory NoteF1 | — | Dec 1, 2014 | A | — | A | — | — | Common Stock | — | — | D |
Explanation of responses
- F1The convertible promissory note has a term of 90 days. The note, including any accrued but unpaid interest, is convertible at the option of the noteholder: (a) upon the closing of any equity financing that occurs during the term of the note, into the securities offered in the financing to other investors at a 5% discount to the price per share paid by other investors in the financing; and (b) upon the maturity date of the note, into the Company's common stock at the volume weighted average closing price of the common stock for the five trading days prior to such conversion.